Full Paper
C8 C9 C10 C11 C12 C13); HRMS (ESI): m/z calcd for [C168H260N10O32]5+
614.9733 [MÀ3PF6 +2H]5+, found: 614.9746.
:
1.87 (m, 4H; H13), 1.72 (quint., J(H4,H3)=3J(H4,H5)=7.3 Hz, 4H; H4),
1.67 (quint., 3J(H4’,H3’)=3J(H4’,H5’)=7.6 Hz, 4H; H4’), 1.51 (quint.,
3J(H7’,H6’)=3J(H7’,H8’)=7.3 Hz, 4H; H7’), 1.42–1.17 (m, 40H; H5 H5’ H6
H6’ H7 H8 H9 H10 H11 H12), 1.39 (s, 18H; H9’), 1.31 ppm (s, 36H; H15’);
13C NMR (151 MHz, CD3CN, 298 K): d=155.6, 152.3, 148.8, 147.3,
147.1, 145.7, 143.2 (CA CC CF CM CR C2’ C10’ C13’ C14’), 128.6 (C1’), 123.7,
122.5, 121.7, 114.3, 113.1, 112.8 (CB CD CE CN CO CP CQ), 122.5 (C11’),
120.8 (C12’), 73.1, 73.0, 71.6, 71.5, 71.3, 71.1, 68.6, 68.3, 68.2, 68.1 (CG
CH CI CJ CK CL CS CT CU CV CW CX), 54.6 (C14), 52.9 (C1), 50.6 (C8’), 49.9
(C3), 38.2 (C16’), 31.7 (C15’), 30.3, 29.9, 29.7, 29.6, 29.1, 28.9, 27.5, 27.4,
26.9, 26.7 (C4 C4’ C5 C5’ C6 C6’ C7 C7’ C8 C9 C10 C11 C12), 30.2 (C13), 28.7
3
Extended molecular muscle 6
Step 1
Carbamoylated compound 5 (49 mg, 2 equiv, 0.12 mmol) was dis-
solved in dry and degassed CH2Cl2 (2.5 mL), then hermaphrodite
molecule 1 (100 mg, 2 equiv, 0.12 mmol) was added to the solu-
tion, followed by Cu(CH3CN)4PF6 (22 mg, 1 equiv, 0.06 mmol) and
a drop of 2,6-lutidine. The reaction mixture was stirred at RT for
48 h, then CH2Cl2 (15 mL) was added to the mixture. The solution
was washed with aqueous disodium ethylenediaminetetraacetate
dihydrate (0.1m; 330 mL). The combined aqueous layers were ex-
tracted with CH2Cl2 (320 mL). The combined organic layers were
dried over MgSO4, filtered, and concentrated under vacuum. The
crude product was purified by using chromatography on a silica
gel column (solvent elution: CH2Cl2/CH3OH 100:0 to 98:2) to afford
the pure di-N-carbamoylated triazole-containing molecular muscle
as a white solid (yield: 96 mg, 65%). Rf: 0.60 (CH2Cl2/CH3OH 95:5);
1H NMR (400 MHz, CD3CN, 298 K): d=7.45 (s, 2H; H1’), 7.30 (brt,
(C9’), 23.7 ppm (C3’); HRMS (ESI): m/z calcd for [C130H210N10O20]4+
588.1439 [MÀ4PF6]4+; found: 588.1444.
:
Step 3
The previously isolated triazolium-containing molecular muscle
(63 mg, 1 equiv, 0.021 mmol) was dissolved in dry CH2Cl2 (0.5 mL).
An excess of hydrogen chloride (2m) in diethyl ether (15 mL) was
added to the solution and the mixture was stirred at 08C for 2 h.
The solution was evaporated, and the residue was then diluted
with Milli-Q water (2 mL). Ammonium hexafluorophosphate
(25 mg, 6 equiv, 0.15 mmol) was introduced and CH2Cl2 (2 mL) was
added to the solution. The resulting bilayer solution was vigorously
stirred at RT for 30 min. After separation, the aqueous layer was ex-
tracted with CH2Cl2 (315 mL). The combined organic layers were
dried over MgSO4, filtered, and concentrated under vacuum to
obtain protonated molecular muscle 6 quantitatively as a beige
solid. Rf: 0.66 (CH2Cl2/CH3OH 9:1); 1H NMR (600 MHz, CD3CN,
298 K): d=8.12 (s, 2H; H1’), 7.21 (s, 2H; H12’), 6.97–6.87, 6.67 (m,
4H; H2), 6.92 (s, 4H; H11’), 6.81 (dd, 4J(HD,HB)=1.7 Hz, 3J(HD,HE)=
8.2 Hz, 2H; HD), 6.79–6.72 (m, 10H; HB HN HO HP HQ), 6.44 (d,
3J(HE,HD)=8.2 Hz, 2H; HE), 4.57–4.41 (m, 4H; H1), 4.46 (t,
3J(H14,H13)=7.2 Hz, 4H; H14), 4.19–3.60 (m, 48H; HG HH HI HJ HK HL
HS HT HU HV HW HX), 4.09 (s, 6H; H16’), 3.47–3.37 (m, 4H; H3), 3.26 (t,
4
4J(H12’,H11’)=1.3 Hz, 2H; H12’), 7.03 (d, 4H; J(H11’,H12’)=1.3 Hz, H11’),
6.97–6.85, 6.68 (m, 4H; H2), 6.85–6.71 (m, 10H; HB HN HO HP HQ),
6.82 (d, 3J(HD,HE)=8.2 Hz, 2H; HD), 6.44 (d, 3J(HE,HD)=8.2 Hz, 2H;
HE), 4.59–4.41 (m, 4H; H1), 4.27 (t, 3J(H14,H13)=7.1 Hz, 4H; H14),
4.19–3.65 (m, 48H; HG HH HI HJ HK HL HS HT HU HV HW HX), 3.60 (t,
3J(H8’,H7’)=7.2 Hz, 4H; H8’), 3.49–3.35 (m, 4H; H3), 2.60 (t,
3J(H3’,H4’)=7.5 Hz, 4H; H3’), 1.82 (quint., 3J(H13,H14)=3J(H13,H12)=
7.1 Hz, 4H; H13), 1.72 (quint., 3J(H4,H3)=3J(H4,H5)=7.2 Hz, 4H; H4),
1.65–1.53 (m, 4H; H4’), 1.53–1.43 (m, 4H; H7’), 1.40 (s, 18H; H9’),
1.42–1.17 (m, 40H; H5 H5’ H6 H6’ H7 H8 H9 H10 H11 H12), 1.30 ppm (s,
36H; H15’); 13C NMR (101 MHz, CD3CN, 298 K): d=155.5, 152.2,
148.8, 148.5, 147.2, 147.0, 143.3 (CA CC CF CM CR C2’ C10’ C13’ C14’),
123.6, 121.7, 114.2, 113.0, 112.8 (CB CD CE CN CO CP CQ), 122.5 (C11’),
122.0 (C1’), 120.7 (C12’), 73.1, 71.6, 71.5, 71.3, 71.1, 68.6, 68.3, 68.1,
68.0 (CG CH CI CJ CK CL CS CT CU CV CW CX), 52.9 (C1), 50.7 (C8’), 50.6
(C14), 49.9 (C3), 31.7 (C15’), 31.0 (C13), 30.2, 30.1, 30.0, 29.7, 29.6, 29.5,
29.1, 27.3, 27.1 (C4’ C5 C5’ C6 C6’ C7 C7’ C8 C9 C10 C11 C12), 27.7 (C9’),
27.3 (C4), 26.2 ppm (C3’); HRMS (ESI): m/z calcd for [C128H205N10O20]3+
: 734.5121 [MÀ2PF6 +1H]3+, found: 734.5139.
3J(H8’,H7’)=7.4 Hz, 4H; H8’), 2.78 (t, J(H3’,H4’)=7.6 Hz, 4H; H3’), 1.97–
3
1.88 (m, 4H; H13), 1.76–1.63 (m, 12H; H4 H4’ H7’), 1.49–1.41
(brquint., 8H; H5’ H6’), 1.40–1.14 (m, 32H; H5 H6 H7 H8 H9 H10 H11
H12), 1.30 ppm (s, 36H; H15’); 13C NMR (101 MHz, CD3CN, 298 K): d=
153.7, 148.7, 147.2, 147.0, 145.7 (CA CC CF CM CR C2’ C10’ C13’ C14’),
128.6 (C1’), 119.0 (C12’), 114.2, 113.1, 112.8, 112.7 (CB CD CE CN CO CP
CQ), 113.4 (C11’), 73.0, 71.6, 71.5, 71.3, 71.1, 68.5, 68.3, 68.1, 68.0 (CG
CH CI CJ CK CL CS CT CU CV CW CX), 54.6 (C14), 52.9 (C1), 49.9 (C3), 49.5
(C8’), 38.2 (C16’), 31.5 (C15’), 30.3, 30.2, 30.1, 29.9, 29.6, 29.0, 28.0,
26.8, 26.7 (C5 C5’ C6 C6’ C7 C8 C9 C10 C11 C12), 29.6 (C13), 27.4 (C4 C4’
Step 2
The previously isolated di-N-carbamoylated triazole-containing mo-
lecular muscle (96 mg, 1 equiv, 0.039 mmol) was dissolved in dry
CH2Cl2 (0.5 mL) and an excess of iodomethane (3 mL) was added
to the solution. The reaction mixture was stirred at RT for 72 h,
then the solution was evaporated and the residue was diluted in
Milli-Q water (2.5 mL). Ammonium hexafluorophosphate (38 mg,
6 equiv, 0.234 mmol) was introduced and CH2Cl2 (2.5 mL) was
added to the solution. The resulting bilayer solution was vigorously
stirred at RT for 1 h. After separation, the aqueous layer was ex-
tracted with CH2Cl2 (315 mL). The combined organic layers were
dried over MgSO4, filtered, and concentrated under vacuum to
obtain the triazolium-containing molecular muscle as a white solid
(yield: 100 mg, 92%). Rf: 0.30 (CH2Cl2/CH3OH 95:5); 1H NMR
C7’), 23.6 ppm (C3’); HRMS (ESI): m/z calcd for [C120H195N10O16]5+
406.6957 [MÀ6PF6ÀH]5+; found: 406.6957.
:
Contracted molecular muscle 7
Extended molecular muscle 6 (61 mg, 1 equiv, 0.021 mmol) was
dissolved in CH2Cl2 (15 mL) and washed with aqueous sodium hy-
droxide (1m; 210 mL), then the aqueous layer was extracted
with CH2Cl2 (315 mL). The combined organic layers were dried
over MgSO4, filtered, and concentrated under vacuum to obtain
the deprotonated contracted molecular muscle 7 quantitatively as
1
a brown solid (yield: 49 mg). Rf: 0.60 (CH2Cl2/CH3OH 9:1); H NMR
4
(600 MHz, CD3CN, 298 K): d=8.11 (s, 2H; H1’), 7.32 (t, J(H12’,H11’)=
(600 MHz, CD3CN, 298 K): d=8.89 (s, 2H; H1’), 6.95–6.75 (m, 14H;
4
4
1.7 Hz, 2H; H12’), 7.04 (d, J(H11’,H12’)=1.7 Hz, 4H; H11’), 6.91, 6.67 (m,
HB HD HE HN HO HP HQ), 6.73 (t, J(H12’,H11’)=1.6 Hz, 2H; H12’), 6.46 (d,
4H; H2), 6.84–6.79 (m, 2H; HD), 6.84–6.71 (m, 10H; HB HN HO HP HQ),
6.44 (d, 3J(HE,HD)=8.2 Hz, 2H; HE), 4.56–4.42 (m, 4H; H1), 4.46 (t,
3J(H14,H13)=7.2 Hz, 4H; H14), 4.19–3.65 (m, 48H; HG HH HI HJ HK HL
4J(H11’,H12’)=1.6 Hz, 4H; H11’), 6.45 (brs, 2H; H9’), 4.91 (brs, 4H; H14),
4.11–3.46 (m, 48H; HG HH HI HJ HK HL HS HT HU HV HW HX), 3.68 (s,
6H; H16’), 3.63 (m, 4H; H1), 3.46–3.30 (m, 4H; H3’), 3.06 (t,
3J(H8’,H7’)=6.5 Hz, 4H; H8’), 2.54–2.43 (m, 4H; H3), 2.05–1.95 (m, 4H;
H13), 1.77–1.59 (m, 4H; H4’), 1.59–1.51 (m, 4H; H7’), 1.46–1.35 (m,
3
HS HT HU HV HW HX), 4.07 (s, 6H; H16’), 3.61 (t, J(H8’,H7’)=7.3 Hz, 4H;
3
H8’), 3.47–3.37 (m, 4H; H3), 2.76 (t, J(H3’,H4’)=7.6 Hz, 4H; H3’), 1.97–
Chem. Eur. J. 2016, 22, 6837 – 6845
6844
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim